SynthesisClinical and experimental medicine2023

Cyclin-dependent kinase 4 and 6 inhibitors in combination with neoadjuvant endocrine therapy in estrogen receptor-positive early breast cancer: a systematic review and meta-analysis.

Yumei Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.